BlackRock’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $225M | Sell |
|
|||||
|
2025
Q2 | $154M | Buy |
|
|||||
|
2025
Q1 | $162M | Sell |
|
|||||
|
2024
Q4 | $196M | Sell |
|
|||||
|
2024
Q3 | $124M | Buy |
|
|||||
|
2024
Q2 | $88.8M | Buy |
|
|||||
|
2024
Q1 | $96.4M | Buy |
|
|||||
|
2023
Q4 | $51M | Buy |
|
|||||
|
2023
Q3 | $39.3M | Buy |
|
|||||
|
2023
Q2 | $39.7M | Buy |
|
|||||
|
2023
Q1 | $18.3M | Buy |
|
|||||
|
2022
Q4 | $19.7M | Buy |
|
|||||
|
2022
Q3 | $19.2M | Buy |
|
|||||
|
2022
Q2 | $14.8M | Buy |
|
|||||
|
2022
Q1 | $7.4M | Sell |
|
|||||
|
2021
Q4 | $10.1M | Buy |
|
|||||
|
2021
Q3 | $9.52M | Buy |
|
|||||
|
2021
Q2 | $12.7M | Buy |
|
|||||
|
2021
Q1 | $11M | Buy |
|
|||||
|
2020
Q4 | $13.3M | Buy |
|